Other deleterious effects of EPAC are ventricular arrhythmias, first described in vitro, and confirmed in transgenic mice for EPAC1 and EPAC2 (Laudette et al., 2018). The gene discussed is RAPGEF4; the disease is Ventricular arrhythmia.